financetom
Business
financetom
/
Business
/
Valaris Shares Rise After Reporting Q3 Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Valaris Shares Rise After Reporting Q3 Earnings, Revenue Increase
Nov 3, 2024 3:42 PM

10:14 AM EDT, 10/31/2024 (MT Newswires) -- Valaris ( VAL ) shares were rising past 7% in recent Thursday trading after the company reported Q3 earnings of $0.88 per diluted share, up from $0.17 a year earlier.

Analysts polled by Capital IQ expected $1.03.

Operating revenue for the quarter ended Sept. 30 was $643.1 million, up from $455.1 million a year earlier.

Analysts surveyed by Capital IQ expected $620.1 million.

Price: 52.23, Change: +3.44, Percent Change: +7.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Huawei 2024 profit drops; revenue rises at fastest rate in five years
China's Huawei 2024 profit drops; revenue rises at fastest rate in five years
Mar 31, 2025
BEIJING/SHENZHEN, March 31 (Reuters) - China's Huawei Technologies said on Monday its profit fell by almost a quarter in 2024 versus a year prior when income from the sale of its Honor handset unit provided an earnings boost, while its revenue grew at the fastest rate in five years. Net profit tumbled 28% to 62.6 billion yuan ($8.63 billion), which...
Medtronic Aortic Valve Replacement Device Shows Improvements Over Surgery in Heart Patients
Medtronic Aortic Valve Replacement Device Shows Improvements Over Surgery in Heart Patients
Mar 31, 2025
04:09 AM EDT, 03/31/2025 (MT Newswires) -- Medtronic ( MDT ) said Sunday that data from a 1,414-patient study of its Evolut transcatheter aortic valve replacement device in patients with severe aortic stenosis showed numerically lower mortality or disabling stroke rates, strong valve performance and durable clinical outcomes compared with surgery at five years. The company said 15.5% of patients...
Eli Lilly Says Heart Disease Risk Factor Therapy Meets Primary Endpoint in Phase 2 Study
Eli Lilly Says Heart Disease Risk Factor Therapy Meets Primary Endpoint in Phase 2 Study
Mar 31, 2025
04:01 AM EDT, 03/31/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Sunday its lepodisiran therapeutic candidate to reduce the production of heart disease risk factor lipoprotein(a) met its primary endpoint in a phase 2 study. The trial showed the highest dose of the product helped lower the production of lipoprotein(a) in patients by an average of 93.9% over...
TABLE-Asian physical rubber prices - March 31
TABLE-Asian physical rubber prices - March 31
Mar 31, 2025
March 31 (Reuters) - Grade Prices Thai RSS3 (April) 80.88 baht/kg Thai STR20 (April) 72.50 baht/kg Thai 60-percent latex (bulk/April) 51.87 baht/kg Malaysia SMR20 (April) N/A Indonesia SIR20 N/A NOTE: Prices are sourced from the Rubber Authority of Thailand, the Malaysian Rubber Board, the International Rubber Consortium, and a private Thai website that collates auction prices. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved